|
Volumn 45, Issue SUPPL. 9, 2000, Pages 25-28
|
Regulation of apoptosis in prostatic disease
|
Author keywords
adrenoceptor blocker; Apoptosis; BPH; Caveolin 1; Prostate cancer
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANDROGEN;
ANTIANDROGEN;
CAVEOLIN;
GANCICLOVIR;
GENE PRODUCT;
PROTEIN BCL 2;
RAS PROTEIN;
TERAZOSIN;
THYMIDINE KINASE;
VIRUS ENZYME;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CELL GROWTH;
CELL SURVIVAL;
CLINICAL TRIAL;
DRUG MECHANISM;
DRUG TARGETING;
GENE THERAPY;
HUMAN;
NONHUMAN;
ONCOGENE MYC;
ONCOGENE RAS;
PALLIATIVE THERAPY;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
PROTEIN EXPRESSION;
TUMOR GROWTH;
GENETICS;
HOMEOSTASIS;
MALE;
PATHOLOGY;
PROSTATE DISEASE;
PROSTATE TUMOR;
REVIEW;
APOPTOSIS;
GENE THERAPY;
HOMEOSTASIS;
HUMANS;
MALE;
PROSTATIC DISEASES;
PROSTATIC HYPERPLASIA;
PROSTATIC NEOPLASMS;
|
EID: 37649007223
PISSN: 02704137
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0045(2000)45:9+<25::AID-PROS6>3.0.CO;2-5 Document Type: Article |
Times cited : (16)
|
References (20)
|